Investigational Site Number 840004

Houston, Texas 77083-4436

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Mellitus, Type 2, Hematopoietic Neoplasm, Stargardt's Disease

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration — Stopped early
• Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist — Completed